ACCC appeals $1.7m Nurofen penalty

Consumer watchdog says fine is inadequate deterrent. The Australian Competition and Consumer Commission (ACCC) is appealing the federal court’s decision to fine Reckitt Benckiser $1.7 million for its Nurofen Specific Pain products range. The commission is calling for its original penalty suggestion of $6 million, “in order to send a strong deterrence message” against misrepresentation of pharmaceutical